Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07132697) titled 'The Efficacy of Intravenous Amino Acids in Reducing the Occurrence of AKI After Live Donor Liver Transplant' on Aug. 13.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: None (Open Label).
Primary Sponsor: Institute of Liver and Biliary Sciences, India
Condition:
Liver Transplant
Complications
AKI - Acute Kidney Injury
Intervention:
Drug: L-Amino acid mixture
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: August 25, 2025
Target Sample Size: 100
Countries of Recruitment:
India
To know...